Comparison of microbiota profiles of fecal samples, rectal swabs and mucosal biopsies in patients with inflammatory bowel disease
Tessel M. van Rossen(Institute of Infection and Immunity), A A Van Bodegraven(Maastricht University Medical Centre), Emma M van Andel(Noordwest Ziekenhuisgroep), Kim van den Hoek(Vrije Universiteit Amsterdam), Gerd Bouma(Amsterdam University Medical Centers), Andries E. Budding(DiscoveryBioMed (United States)), Thomas Groot(DiscoveryBioMed (United States)), Paul H. M. Savelkoul(Maastricht University Medical Centre), Matthijs E. Grasman(Northwest Hospital), Nanne K.H. de Boer, Maysa L. M. van Doorn-Schepens(Lady of Mercy Medical Center), Rob H. Creemers(Zuyderland Medisch Centrum)
Cited by 1
Related Papers
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
|Clinical Microbiology and Infection|2021|615
Non-Celiac Gluten Sensitivity: The New Frontier of Gluten Related Disorders
|Nutrients|2013|493
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
|Nature Communications|2018|252